Inhaled β2 agonist, such as albuterol, is the drug of choice for acute severe exacerbation of<unk> . In cases of mild to moderate exacerbations, metered-dose inhalation (MDI) of a β2 agonist in conjunction with a spacer may be used. In more severe exacerbations, nebulized β2 agonist has been demonstrated to be most effective. In case of severe exacerbation with non- reponsiveness to β2 agonist inhalation/anticholinergic therapy, parenteral β2 agonist such as terbutaline may be administered. Ipratropium may also be utilized in cases of severe exacerbation. Steroid therapy remains the mainstay of therapy in the treatment of acute and sub-acute phases of exacerbation. Steroids speed in the resolution of airway obstruction and prevent a late-phase response; hence, shown to provide highly beneficial outcomes to patients with acute exacerbation presenting to the<unk>  department.
Asthma emergency management
Adult bronchiolitis medical therapy
Respiratory disease medical therapy
Chronic bronchitis medical therapy
Epiglottitis medical therapy
Acute respiratory distress syndrome medical therapy
Pharyngitis medical therapy
Bronchitis medical therapy